Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Survey finds neurologists seek to minimize side effects of treatment in Parkinson’s
Fewer than half of those dealing with Parkinson’s disease in the United States are able to gain clinical control of symptoms without experiencing side effects, according to results of a new study.
How behavioral finance impacts physicians’ decision making
Investing in the financial markets is a complex endeavor influenced not only by economic factors and market dynamics but also by human behavior.
Log in or Sign up for Free to view tailored content for your specialty!
Intervention for uncontrolled hypertension also lowers dementia risk
PHILADELPHIA — A 48-month intervention to lower BP in patients with uncontrolled hypertension also reduced risk for dementia and cognitive impairment, according to data presented at the American Heart Association Scientific Sessions.
RetinalGeniX applies for dry AMD, Alzheimer’s treatment patents
RetinalGeniX Technologies announced that it submitted patent applications for investigational drug candidates RTG-2023 and RTG-2024, for age-related macular degeneration and Alzheimer’s, respectively.
Foundation provides $1.5 million grant for ongoing PTSD, TBI treatment study
The Engelstad Foundation has provided a $1.5 million grant to Wave Neuroscience in support of the company’s ongoing phase 2 clinical trial to develop and validate innovative treatments for post-traumatic stress disorder and traumatic brain injury.
National Epilepsy Awareness Month: Effective cannabinoid therapies and more
As November is National Epilepsy Awareness Month, Healio has gathered the most recent top stories about the condition that affects 3.4 million Americans each year.
First patients dosed in clinical trial of small molecule for MS, autoimmune conditions
A Boston-based biopharma company announced the first participants have been dosed in its phase 1 study to assess safety, tolerability and pharmacokinetics of a novel oral, small molecule therapeutic in healthy adults.
VIDEO: Sleep, circadian rhythms may contribute to ‘seizure propagation network’
In this Healio video, Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses a new perspective on how sleep and circadian rhythms influence seizures.
Brexpiprazole improves agitation in patients with Alzheimer’s dementia over 12 weeks
Treatment with brexpiprazole 2 mg or 3 mg resulted in significant reduction in agitation over 12 weeks compared with placebo in adults with Alzheimer’s dementia, according to research published in JAMA Neurology.
VIDEO: Uncovering connection between seizures, sleep in children
In this Healio video, Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses highlights from a session at the Child Neurology Society annual meeting.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read